NCT04792424View on ClinicalTrials.gov

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

June 15, 2022

Conditions
Regional Citrate AnticoagulationIonized CalciumContinuous Renal Replacement Therapy
Interventions
OTHER

Regional citrate anticoagulation

Starting RCA 4 mmol/L (adjust the rate by BFR)

DRUG

Vasopressor

Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine

DRUG

Antibiotic

Antibacterial agents deemed appropriate by physicians in the ICU

DEVICE

Dialysis with continuous renal replacement therapy

Prismaflex

Trial Locations (1)

10330

Chulalongkorn university, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT04792424 - No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation | Biotech Hunter | Biotech Hunter